The DOI matches its Crossref record; its reference list is not available.
Short-term and Long-term Efficacy of Gastric Peroral Endoscopic Myotomy for Refractory Gastroparesis: A Meta-analysis
Abstract
Background Gastric peroral endoscopic myotomy (G-POEM) is an emerging endoscopic approach to treat refractory gastroparesis (GP). Previous studies have shown short-term benefits, but the long-term outcomes are unclear. This analysis evaluated the short- and long-term efficacy of G-POEM compared with standard medical treatment for adults with refractory GP. Methods We performed a systematic review and meta-analysis of studies that evaluated G-POEM for refractory GP. Clinical success was defined variably across studies, most commonly as a ≥50% reduction in Gastroparesis Cardinal Symptom Index (GCSI) scores or combined symptoms and gastric emptying improvement. Pooled estimates for clinical success, GCSI scores, and gastric emptying scintigraphy (GES) were calculated using a random effects model. Adverse events and predictors of long-term outcomes were assessed. Results This meta-analysis included 23 studies involving 871 patients who underwent G-POEM. The clinical response rates remained consistently above 70% during the first year, peaked at 79% at 24 months, and reached 81% at 60 months. G-POEM was associated with significant and durable reductions in GCSI scores at 1 month (SMD -2.68, 95% CI: -3.58 to -1.78), 12 months (SMD -2.12, 95% CI: -2.73 to -1.50), and 60 months (SMD -2.55, 95% CI: -4.88 to -0.23), as well as sustained improvements in gastric emptying at 12 months (SMD -33.60%, P Conclusions G-POEM may offer sustained symptoms and gastric emptying improvement in refra…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“G‑POEM (gastric per‑oral endoscopic myotomy), which reduce pyloric resistance improve symptoms in refractory DGP, with success rates around 70% at 1 year in small series [129, 130];”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [130]
Citations
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 39 · Cited by 3
Research works printed but not linked: 37
- Schol, 2021, United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis, United European Gastroenterol J, 9, 287, 10.1002/ueg2.12060 · DOI
- Mekaroonkamol, 2022, A new paradigm shift in gastroparesis management, Gut Liver, 16, 825, 10.5009/gnl210309 · DOI
- Wadhwa, 2017, Healthcare utilization and costs associated with gastroparesis, World J Gastroenterol, 23, 4428, 10.3748/wjg.v23.i24.4428 · DOI
- Myint, 2018, Current and emerging therapeutic options for gastroparesis, Gastroenterol Hepatol (N Y), 14, 639
- McCurdy, 2023, Gastric peroral endoscopic pyloromyotomy (G-POEM) in patients with refractory gastroparesis: a review, Therap Adv Gastroenterol, 16, 17562848231151289, 10.1177/17562848231151289 · DOI
- Zhang, 2019, Gastric peroral endoscopic myotomy for gastroparesis: a systematic review of efficacy and safety, Gastroenterol Hepatol, 42, 413, 10.1016/j.gastrohep.2019.01.008 · DOI
- Mekaroonkamol, 2019, Gastric peroral endoscopic pyloromyotomy reduces symptoms, increases quality of life, and reduces health care use for patients with gastroparesis, Clin Gastroenterol Hepatol, 17, 82, 10.1016/j.cgh.2018.04.016 · DOI
- Abdelfatah, 2021, Long-term outcome of gastric per-oral endoscopic pyloromyotomy in treatment of gastroparesis, Clin Gastroenterol Hepatol, 19, 816, 10.1016/j.cgh.2020.05.039 · DOI
- Shen, 2020, Gastric peroral endoscopic pyloromyotomy versus gastric electrical stimulation in the treatment of refractory gastroparesis: a propensity score-matched analysis of long term outcomes, Endoscopy, 52, 349, 10.1055/a-1111-8566 · DOI
- Hernández Mondragón, 2022, Gastric peroral endoscopic myotomy outcomes after 4 years of follow-up in a large cohort of patients with refractory gastroparesis (with video), Gastrointest Endosc, 96, 487, 10.1016/j.gie.2022.03.025 · DOI
- Labonde, 2022, Gastric peroral endoscopic myotomy in refractory gastroparesis: long-term outcomes and predictive score to improve patient selection, Gastrointest Endosc, 96, 500, 10.1016/j.gie.2022.04.002 · DOI
- Gregor, 2021, Gastric peroral endoscopic myotomy for the treatment of refractory gastroparesis: a prospective single-center experience with mid-term follow-up (with video), Gastrointest Endosc, 94, 35, 10.1016/j.gie.2020.12.030 · DOI
- Xu, 2018, Gastric peroral endoscopic myotomy (G-POEM) as a treatment for refractory gastroparesis: long-term outcomes, Can J Gastroenterol Hepatol, 2018, 6409698, 10.1155/2018/6409698 · DOI
- Vosoughi, 2022, Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial, Gut, 71, 25, 10.1136/gutjnl-2020-322756 · DOI · Paper page
- Ichkhanian, 2023, Gastric peroral endoscopic myotomy for management of refractory gastroparesis in patients with gastric neurostimulator devices: a multicenter retrospective case control study, Gastrointest Endosc, 98, 559, 10.1016/j.gie.2023.04.2079 · DOI
- Conchillo, 2021, Gastric peroral endoscopic pyloromyotomy for decompensated gastroparesis: comprehensive motility analysis in relation to treatment outcomes, Endosc Int Open, 9, E137, 10.1055/a-1311-0859 · DOI
- Gourcerol, 2023, Gastric electrical stimulation versus per-oral pyloromyotomy for the treatment of nausea and vomiting associated with gastroparesis: an observational study of two cohorts, Neurogastroenterol Motil, 35, e14565, 10.1111/nmo.14565 · DOI
- Dacha, 2017, Outcomes and quality-of-life assessment after gastric per-oral endoscopic pyloromyotomy (with video), Gastrointest Endosc, 86, 282, 10.1016/j.gie.2017.01.031 · DOI
- Chung, 2022, Efficacy and safety of gastric peroral endoscopic myotomy (G-POEM) for refractory gastroparesis: 3-year follow up results, J Formos Med Assoc, 121, 1334, 10.1016/j.jfma.2021.08.029 · DOI
- Reja, 2022, Gastric peroral endoscopic myotomy: a specific learning curve, J Clin Gastroenterol, 56, 339, 10.1097/MCG.0000000000001537 · DOI
- Husťak, 2020, Per-oral endoscopic pyloromyotomy (g-poem) for the treatment of gastroparesis - a pilot single-centre study with mid-term follow-up, Rozhl Chir, 99, 116, 10.33699/PIS.2020.99.3.116-123 · DOI
- Ragi, 2021, One-year results of gastric peroral endoscopic myotomy for refractory gastroparesis: a French multicenter study, Endoscopy, 53, 480, 10.1055/a-1205-5686 · DOI
- Kahaleh, 2018, Gastric peroral endoscopic myotomy for the treatment of refractory gastroparesis: a multicenter international experience, Endoscopy, 50, 1053, 10.1055/a-0596-7199 · DOI
- Gonzalez, 2017, G-POEM with antro-pyloromyotomy for the treatment of refractory gastroparesis: mid-term follow-up and factors predicting outcome, Aliment Pharmacol Ther, 46, 364, 10.1111/apt.14132 · DOI
- Khashab, 2017, Gastric per-oral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video), Gastrointest Endosc, 85, 123, 10.1016/j.gie.2016.06.048 · DOI
- Malik, 2018, Gastric per oral endoscopic myotomy (G-POEM) for the treatment of refractory gastroparesis: early experience, Dig Dis Sci, 63, 2405, 10.1007/s10620-018-4976-9 · DOI
- Tan, 2024, A long-term follow-up study of gastric peroral endoscopic myotomy (G-POEM) in a large cohort of patients with postsurgical gastroparesis, Surg Endosc, 38, 7416, 10.1007/s00464-024-11184-0 · DOI
- Azzolini, 2020, Gastric peroral endoscopic myotomy (G-POEM) for refractory gastroparesis: 3-month follow-up results, Dig Liver Dis, 52, 1215, 10.1016/j.dld.2020.07.023 · DOI
- Martinek, 2022, Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis: a pilot, randomised, sham-controlled trial, Gut, 71, 2170, 10.1136/gutjnl-2022-326904 · DOI
- Aghaie Meybodi, 2019, Efficacy and feasibility of G-POEM in management of patients with refractory gastroparesis: a systematic review and meta-analysis, Endosc Int Open, 7, E322, 10.1055/a-0812-1458 · DOI
- Malik, 2025, Efficacy and safety of gastric peroral endoscopic myotomy across different etiologies of gastroparesis: systematic review and meta-analysis, Gastrointest Endosc, 101, 54, 10.1016/j.gie.2024.08.024 · DOI
- Canakis, 2023, Long-term outcomes (≥3 years) after gastric peroral endoscopic myotomy for refractory gastroparesis: a systematic review and meta-analysis, iGIE, 2, 344, 10.1016/j.igie.2023.07.007 · DOI
- Varghese, 2024, Predictors of outcomes after gastric peroral endoscopic myotomy for refractory gastroparesis: a systematic review, Am J Gastroenterol, 120, 1275, 10.14309/ajg.0000000000003213 · DOI
- Camilleri, 2022, ACG clinical guideline: gastroparesis, Am J Gastroenterol, 117, 1197, 10.14309/ajg.0000000000001874 · DOI · Paper page
- Wise, 2023, Response and adverse event rates with placebo in gastroparesis: a systematic review and meta-analysis, Clinical Gastroenterology and Hepatology, 21, 1447, 10.1016/j.cgh.2022.09.033 · DOI
- Chen, 2025, The American Neurogastroenterology and Motility Society Gastroparesis Cardinal Symptom Index-Daily Diary (ANMS GCSI-DD): psychometric validation and meaningful change threshold in patients with idiopathic or diabetic gastroparesis, Neurogastroenterol Motil, 37, e14960, 10.1111/nmo.14960 · DOI
- Pasricha, 2017, White Paper AGA: gastroparesis: clinical and regulatory insights for clinical trials, Clin Gastroenterol Hepatol, 15, 1184, 10.1016/j.cgh.2017.04.011 · DOI
Metadata
- Authors
- Khan, S., Shafiq, M., Khan, M. A., Ahmad, A., Ehsan, N., Ahmad, N., Tripathi, A., & Esfandyari, T.
- Affiliations
- University of Kansas Medical Center (US)
- Khyber Medical University (PK)
- Corresponding author
- Khan, Shahryar
- Shafiq, Muhammad
- Tripathi, Alok
- Venue
- Journal of Clinical Gastroenterology
- Published
- 2025-11-11
- ISSN
- 0192-0790 (ISSN-L)
- 1539-2031
- OpenAlex
- W4416112182
- Cited by
- 3
- References
- 39
- Citations by year
- 2026: 3
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
- Keywords
- gastric peroral endoscopic myotomy, refractory gastroparesis, long-term efficacy, Gastroparesis Cardinal Symptom Index, gastric emptying, idiopathic gastroparesis, botulinum toxin injection, adverse events, symptom severity, disease duration, predictors of treatment response, predictors of treatment failure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review